What do they tell us about cancer control in Australia?
There have been some spectacular trends, both good and bad, in cancer incidence and mortality in Australia over the past three decades. Using data from the Australian Institute of Health and Welfare (AIHW),1 the annual average percentage change in incidence and mortality of the most common cancers in Australia can be calculated for this period, as shown in the Box. Perhaps the most notable trends are annual 5%–6% rises in the incidence of hepatic and prostatic cancers and 4%–5% falls in mortality from Hodgkin lymphoma and cervical and testicular cancers. These examples reflect the annual trends in the rates of all cancers: increasing incidence of 0.7% (95% CI, 0.5%–0.9%) and falling mortality of 1.4% (95% CI, 1.2%–1.5%).
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Australian Institute of Health and Welfare. Australian cancer incidence and mortality (ACIM) books. Canberra: AIHW, 2012. http://www.aihw.gov.au/acim-books (accessed Oct 2013).
- 2. Amin J, O’Connell D, Bartlett M, et al. Liver cancer and hepatitis B and C in New South Wales, 1990–2002: a linkage study. Aust N Z J Public Health 2007; 31: 475-482.
- 3. Aminisani N, Armstrong BK, Egger S, Canfell K. Impact of organised cervical screening on cervical cancer incidence and mortality in migrant women in Australia. BMC Cancer 2012; 12: 491.
- 4. Smith DP, Supramaniam R, Marshall VR, Armstrong BK. Prostate cancer and prostate-specific antigen testing in New South Wales. Med J Aust 2008; 189: 315-318. <MJA full text>
- 5. Kahn C, Simonella L, Sywak M, et al. Pathways to the diagnosis of thyroid cancer in New South Wales: a population-based cross-sectional study. Cancer Causes Control 2012; 23: 35-44.
- 6. Marcus R, Hagenbeek A. The therapeutic use of rituximab in non-Hodgkin’s lymphoma. Eur J Haematol Suppl 2007; (67): 5-14.
- 7. Rutten H, den Dulk M, Lemmens V, et al. Survival of elderly rectal cancer patients not improved: analysis of population based data on the impact of TME surgery. Eur J Cancer 2007; 43: 2295-2300.
- 8. Australian Institute of Health and Welfare. Health system expenditure on disease and injury in Australia, 2004-05. Canberra: AIHW, 2010. (AIHW Cat. No. HSE 87; Health and Welfare Expenditure Series No. 36.) http://www.aihw.gov.au/publication-detail/?id=6442468349 (accessed Sep 2013).
- 9. Roder DM. The epidemiology of gastric cancer. Gastric Cancer 2002; 5 Suppl 1: 5-11.
- 10. Thein HH, Walter SR, Gidding HF, et al. Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population-based cohort study, 1992-2007. J Viral Hepat 2011; 18: e232-e241.
Chris Goumas did the statistical analysis of annual percentage changes in cancer rates.
No relevant disclosures.